Molnupiravir: A New COVID 19 Treatment Pill Explained Clearly

Share

MedCram – Medical Lectures Explained CLEARLY

Roger Seheult, MD of MedCram on how the molnupiravir pill works as a possible treatment for COVID 19. Safety and efficacy data are reviewed from the study that Merck conducted, and the mechanism of action is illustrated.


Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.

LINKS / REFERENCES:

Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death (Merck) | https://www.merck.com/news/merck-and-…

Early safety concerns accompanied Merck’s molnupiravir, the first potential oral COVID-19 therapy (Drug Discovery & Development) | https://www.drugdiscoverytrends.com/e…

Molnupiravir vs. COVID-19: Will the drug live up to the hype? (Medical News Today) | https://www.medicalnewstoday.com/arti…